115. Hereditary periodic paralysis
[
1 clinical trial,
2 drugs（DrugBank:
2 drugs),
13 target genes / 7 target pathways ]
Searched query = "Hereditary periodic paralysis", "Hereditary Hypokalemic Periodic Paralysis", "Hereditary Hyperkalemic Periodic Paralysis", "Andersen Tawil syndrome"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00839501 | December 2008 | 19 February 2015 | Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome | Therapeutic Trial of Potassium and Acetazolamide in Andersen-Tawil Syndrome | Andersen-Tawil Syndrome | Dietary Supplement: Potassium;Drug: Acetazolamide | University of Rochester | Office of Rare Diseases (ORD);Rare Diseases Clinical Research Network;National Institute of Neurological Disorders and Stroke (NINDS) | Not recruiting | 10 Years | N/A | Both | 3 | Phase 1 | United States;United Kingdom |